Certolizumab is marketed under which brand name?

Certolizumab is marketed under which brand name?

• A. Humira
• B. Remicade
• C. Cimzia
• D. Enbrel

Answer: (C)

Brand names for biologic therapies help you connect the specific molecule to the product you’ll actually prescribe or dispense. Certolizumab pegol is a TNF-alpha inhibitor, and its marketed brand name is Cimzia. The name Cimzia identifies certolizumab pegol specifically, distinguishing it from other anti-TNF agents that have different brand names—Humira (adalimumab), Remicade (infliximab), and Enbrel (etanercept). Certolizumab pegol is a PEGylated Fab' fragment, which is a structural detail that sets it apart from the full antibodies or fusion proteins used by the other drugs. This helps explain why each product has its own brand name even though they share the same general target.

Brand names for biologic therapies help you connect the specific molecule to the product you’ll actually prescribe or dispense. Certolizumab pegol is a TNF-alpha inhibitor, and its marketed brand name is Cimzia. The name Cimzia identifies certolizumab pegol specifically, distinguishing it from other anti-TNF agents that have different brand names—Humira (adalimumab), Remicade (infliximab), and Enbrel (etanercept). Certolizumab pegol is a PEGylated Fab' fragment, which is a structural detail that sets it apart from the full antibodies or fusion proteins used by the other drugs. This helps explain why each product has its own brand name even though they share the same general target.